Vigmed AB signs Distribution Agreement for Italy with Medica Valeggia s.p.a.
Vigmed builds their Italian partnership by signing an exclusive distribution agreement with Medica Valeggia s.p.a. (Medival) for Italy (excluding the regions of Piedmont, Aosta Valley & Tuscany). Formed in 1981, Medival is a leading distributor organisation to the Italian hospital sector and the Vigmed range of products fit well with the quality and technical offers Medival brings to the market.
Vigmed has added to the Italian network of distributors by signing an exclusive distribution agreement for the whole Italian market excluding Piemonte & Aosta Valley (the subject of a previous news release) and Tuscany regions. Medica Valeggia s.p.a. (Medival) will be the chief distributor of the Vigmed products for Italy and will provide logistics support for the other regions.
“Medival provides an excellent platform for Vigmed in Italy.” says Mike Dooley, European Sales Director for Vigmed. “Their strength is in having direct contact with customers, through their network of sales specialists, offering a complimentary range of products as well as support and training.”
Andrea De Benetti Valeggia, Executive Vice President of Medival explains “The Vigmed products offer a quality, cost effective solution to a major issue for Health Care Professionals when it comes to protecting against needlestick injuries. With our sales network we believe we can make a significant difference in the Italian market with these products.”
The joint product launch in Italy is expected to take place in June of this year, with deliveries taking place from then onwards.
For further information contact:
Chairman of the board, Lennart Holm 46 70-630 8562 or CEO, Finn Ketler 46 42 600 5311
Vigmed is a Swedish medical technology company whose mission is to eliminate needlestick injuries by offering the market unique needle-protected products. Vigmed is headquartered in Helsingborg, Sweden, and has approximately 15 employees. Vigmed’s share is traded on NASDAQ OMX First North in Stockholm (ticker VIG) and has approximately
5 400 shareholders. Remium Nordic AB is the Company’s Certified Advisor.
Additional information such as company description, a video presentation and risk factors can be found on Vigmed’s website: www.vigmed.com/investor
Tags:
